97 related articles for article (PubMed ID: 28272917)
1. Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study.
Al-Eitan LN; Jamous RI; Khasawneh RH
Cancer Invest; 2017 Apr; 35(4):256-270. PubMed ID: 28272917
[TBL] [Abstract][Full Text] [Related]
2. Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study.
Al-Eitan LN; Rababa'h DM; Alghamdi MA; Khasawneh RH
BMC Cancer; 2019 Dec; 19(1):1257. PubMed ID: 31888550
[TBL] [Abstract][Full Text] [Related]
3. Candidate gene association analysis of multiple sclerosis in the Jordanian Arab population: A case-control study.
Al-Eitan L; Al Qudah M; Al Qawasmeh M
Gene; 2020 Oct; 758():144959. PubMed ID: 32683075
[TBL] [Abstract][Full Text] [Related]
4. Genetic association analysis of ERBB4 polymorphisms with the risk ofschizophrenia susceptibility in a Jordanian population of Arab descent.
Al-Eitan L; Al-Habahbeh S; Alkhatib R
Turk J Med Sci; 2017 Apr; 47(2):542-553. PubMed ID: 28425244
[TBL] [Abstract][Full Text] [Related]
5. Characterization of serotonin transporter gene (SLC6A4) polymorphisms and its association with drug dependence in a Jordanian Arab population.
Al-Eitan LN; Jaradat SA; Qin W; Wildenauer DM; Wildenauer DD; Hulse GK; Tay GK
Toxicol Ind Health; 2014 Aug; 30(7):598-610. PubMed ID: 23033208
[TBL] [Abstract][Full Text] [Related]
6. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
[TBL] [Abstract][Full Text] [Related]
7. Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population.
Al-Eitan LN; Rababa'h DM; Alghamdi MA; Khasawneh RH
BMC Med Genet; 2019 Sep; 20(1):148. PubMed ID: 31477036
[TBL] [Abstract][Full Text] [Related]
8. Candidate gene analysis of asthma in a population of Arab descent: a case-control study in Jordan.
Almomani BA; Al-Eitan LN; Samrah SM; Al-Quasmi MN; McKnight AJ
Per Med; 2017 Jan; 14(1):51-61. PubMed ID: 29749828
[TBL] [Abstract][Full Text] [Related]
9. The Associations of Common Genetic Susceptibility Variants with Breast Cancer in Jordanian Arabs: A Case-Control Study.
Al-Eitan LN; M Rababa'h D; Aman HA
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3045-3054. PubMed ID: 33112566
[TBL] [Abstract][Full Text] [Related]
10. Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent.
Al-Eitan LN; Jaradat SA; Hulse GK; Tay GK
BMC Res Notes; 2012 Sep; 5():497. PubMed ID: 22963930
[TBL] [Abstract][Full Text] [Related]
11. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Candidate Single Nucleotide Variants and Several Clinicopathological Risk Factors Related to Breast Cancer in Jordanian Women: A Genotype-Phenotype Study.
Al-Eitan LN; Rababa'h DM; Alghamdi MA; Khasawneh RH
J Cancer; 2019; 10(19):4647-4654. PubMed ID: 31528229
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic landscape of VIP genetic variants in Jordanian Arabs and comparison with worldwide populations.
Al-Eitan LN
Gene; 2020 May; 737():144408. PubMed ID: 32007583
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.
El Saghir NS; Zgheib NK; Assi HA; Khoury KE; Bidet Y; Jaber SM; Charara RN; Farhat RA; Kreidieh FY; Decousus S; Romero P; Nemer GM; Salem Z; Shamseddine A; Tfayli A; Abbas J; Jamali F; Seoud M; Armstrong DK; Bignon YJ; Uhrhammer N
Oncologist; 2015 Apr; 20(4):357-64. PubMed ID: 25777348
[TBL] [Abstract][Full Text] [Related]
15. Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs.
Alkhateeb A; Qarqaz F
Arch Dermatol Res; 2010 Oct; 302(8):631-4. PubMed ID: 20574744
[TBL] [Abstract][Full Text] [Related]
16. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
[TBL] [Abstract][Full Text] [Related]
17. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
[TBL] [Abstract][Full Text] [Related]
18. Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping.
Ellis NA; Kirchhoff T; Mitra N; Ye TZ; Chuai S; Huang H; Nafa K; Norton L; Neuhausen S; Gordon D; Struewing JP; Narod S; Offit K
Genet Epidemiol; 2006 Jan; 30(1):48-61. PubMed ID: 16206141
[TBL] [Abstract][Full Text] [Related]
19. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
Tinholt M; Viken MK; Dahm AE; Vollan HK; Sahlberg KK; Garred O; Børresen-Dale AL; Jacobsen AF; Kristensen V; Bukholm I; Kåresen R; Schlichting E; Skretting G; Lie BA; Sandset PM; Iversen N
BMC Cancer; 2014 Nov; 14():845. PubMed ID: 25407022
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
